HIV Populations
IAS 2015: Implant and Injectable Hormonal Contraception Most Effective Methods for Women with HIV
- Details
- Category: Pregnancy & HIV MTCT
- Published on Tuesday, 11 August 2015 00:00
- Written by Carole Leach-Lemens
Hormonal contraceptive methods are highly effective in reducing the risk of pregnancy in women living with HIV whether on antiretroviral therapy (ART) or not, according to an evaluation involving over 5000 women, according to a report at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention in Vancouver last month.
IAS 2015: Intensification of ART Reduces Risk of Late-term Mother-to-Child HIV Transmission
- Details
- Category: Pregnancy & HIV MTCT
- Published on Wednesday, 05 August 2015 00:00
- Written by Carole Leach-Lemens
Maternal and infant antiretroviral therapy (ART) intensification is very effective in preventing HIV transmission during labor and birth from pregnant women with HIV in Thailand who present late for care, with less than 8 weeks of standard ART, Marc Lallemant reported at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) last month in Vancouver.
IAS 2015: Presumptive Treatment of TB in Advanced HIV No Better than ART and Isoniazid
- Details
- Category: People Who Inject Drugs
- Published on Thursday, 23 July 2015 00:00
- Written by Keith Alcorn
Giving treatment for tuberculosis (TB) to all people with very advanced HIV disease at the time they start antiretroviral therapy (ART), before a laboratory diagnosis of TB -- so-called empiric treatment -- does not reduce the risk of death compared to giving ART and isoniazid preventive therapy, according to findings presented by Mina Hosseinipour at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention this week in Vancouver.
IAS 2015: Raltegravir Prevents Mother-to-Child HIV Transmission During Late Pregnancy
- Details
- Category: Pregnancy & HIV MTCT
- Published on Monday, 27 July 2015 00:00
- Written by Liz Highleyman
Combination antiretroviral therapy containing the integrase inhibitor raltegravir (Isentress) appears safe and effective and may be an attractive option for treatment of pregnant women with HIV -- and potentially their infants -- to prevent perinatal transmission, according to study findings presented at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention last week in Vancouver.
Heroin Use Increasing in U.S. Population, Linked to Overdose Deaths, CDC Says
- Details
- Category: People Who Inject Drugs
- Published on Thursday, 09 July 2015 00:00
- Written by Liz Highleyman
Heroin use has increased among men and women across most age groups and all income levels in recent years, according to the July 7 Vital Signs report from the U.S. Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA). The report urges a 3-prong response, including preventing people from starting heroin use, treating heroin addiction, and using naloxone (Narcan) to prevent overdose deaths.
Web Design and Development by